IP Library › Patent Application 17627477
Patent Application
App. No. 17/627,477

A PROCESS FOR SEPARATION AND QUANTITATION OF PROTEINS USING CAPILLARY ELECTROPHORESIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/627,477
Abstract

The present disclosure provides a method for analyzing, detecting and separating at least one low molecular weight impurity from a protein mixture using capillary electrophoresis, e.g., capillary electrophoresis-sodium dodecyl sulfate (CE-SDS). The present disclosure further provides methods to improve protein peak separation efficiency and quantification of a protein. Furthermore, the present disclosure provides an improved reduced CE-SDS method for analyzing a protein mixture comprising protein of interest which is pegylated and separates LMW or HMW fragments present in the protein mixture.

Claims (51)

1 . A process for the quantification and/or detection of impurity in the protein mixture comprises;

a. Protein mixture comprising at least the impurity and the protein of interest, wherein the protein mixture does not contain an antibody;

b. Mixing the protein mixture with a suitable buffer and detergent;

c. Optionally incorporating a 10 kDa marker into the treated protein mixture;

d. Injecting the treated protein mixture in CE-instrument;

e. Performing CE SDS by injecting the treated protein mixture in a CE-instrument at suitable temperature; and

f. Detecting and/or quantifying the impurity;

wherein the impurity is selected from LMW impurity and HMW impurity.

2 . The process according to claim 1 further comprises mixing the protein mixture in step (b) with reducing agent capable of denaturing the protein and reducing noncovalent bonds in the protein mixture.

3 . The process according to claim 2 wherein the reducing agent is selected from DTT, B-mercaptoethanol and TCEP.

4 . The process according to claim 1 wherein the detergent is sodium dodecyl sulphate or SDS.

5 . The process according to claim 1 wherein the SDS concentration is 1%.

6 . The process according to claim 1 wherein the protein mixture further comprises water or buffer.

7 . The process according to claim 1 wherein the protein mixture is at least 2 mg/ml.

8 . The process according to claim 7 wherein the protein mixture is at least 2 mg/ml to 5 mg/ml.

9 . The process according to claim 1 wherein the protein mixture does not comprise an antibody and/or fragment thereof.

10 . The process according to claim 1 wherein the suitable temperature of CE-SDS capillary is below 25° C.

11 . The process according to claim 10 wherein the capillary temperature is selected from 15° C., 16° C., 17° C., 18° C., 19° C., 20° C., 21° C., 22° C.

12 . The process according to claim 11 wherein the capillary temperature is 15° C.

13 . The process according to claim 1 wherein the quantification or detection of low molecular weight or high molecular weight impurity is improved compared to CE-SDS performed at 25° C.

14 . The process according to claim 1 wherein the CE-SDS is performed at separation voltage at about 15 kV or −15 kV for at least about 30 minutes.

15 . The process according to claim 1 wherein the CE-SDS is performed at an injection voltage of about 5 kV or −5 kV for at least about 10 seconds.

16 . The process according to claim 1 wherein the CE-SDS is performed with Tris buffer at pH 9.

17 . The process according to claim 1 wherein the suitable buffer is Tris.

18 . The process according to claim 16 wherein the Tris concentration is selected from 60 mM to 90 mM.

19 . The process according to claim 1 wherein the low molecular weight impurity is less than about 38 KDa.

20 . The process according to claim 1 wherein the low molecular weight impurity is GCSF or any other fragments derived from PEG-GCSF.

21 . The process according to claim 1 wherein the high molecular weight impurity is higher than about 38 KDa.

22 . A process for an improving protein peak separation efficiency in CE-SDS comprising:

a. Providing a protein mixture comprising a LMW impurity having a molecular weight of at least about 18 kDa, and a protein of interest having a molecular weight of about 38 kDa;

b. Mixing the protein mixture with Tris, SDS and 2-mercaptoethanol to form a treated protein mixture;

c. Injecting the treated protein mixture in CE-SDS;

d. Performing the CE-SDS with capillary temperature below 25° C. to separate the LMW impurity from the protein having a molecular weight of about 38 kDa; and

e. Separating the LMW impurity from the protein having a molecular weight of about 38 kDa through CE-SDS

wherein the separation is improved compared to CE-SDS performed at 25° C.

23 . A process for the quantification and/or detection of GCSF in the protein mixture comprises;

a. Protein mixture comprising the GCSF, pegylated GCSF and suitable buffer or water;

b. Mixing the protein mixture with Tris buffer, SDS and 2-mercaptoethanol to form a treated protein mixture;

c. Optionally incorporating a 10 kDa marker into the treated protein mixture;

d. Injecting the treated protein mixture in CE-instrument;

e. Performing the CE-SDS to separate the GCSF from pegylated GCSF; and

f. Detecting and/or quantifying the GCSF;

wherein the CE-SDS provide improved quantification and/or detection of GCSF or any other fragment compared to CE-SDS performed at 25° C.

24 . A process for the analysis of PEG-GCSF comprising;

a. Preparing a protein mixture comprising the pegylated GCSF in suitable buffer or water;

b. Mixing the protein mixture with Tris buffer, SDS and 2-mercaptoethanol to form a treated protein mixture;

c. Optionally incorporating a 10 kDa marker into the treated protein mixture;

d. Injecting the treated protein mixture in CE-instrument;

e. Performing the CE-SDS with keeping capillary temperature below 25° C.; and

f. Analyzing the protein mixture to evaluate presence of unpegylated GCSF;

wherein the CE-SDS provide improved analysis of unpegylated GCSF compared to CE-SDS performed at 25° C.

Assignments (3)
SHORT FORM TERM LOAN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 3, 2025
From: KASHIV BIOSCIENCES, LLC
To: ACQUIOM AGENCY SERVICES, AS COLLATERAL AGENT
Reel/Frame 071824/0222 →
SHORT FORM TERM LOAN INTELLECTUAL PROPERTY ASSIGNMENT Recorded May 1, 2025
From: KASHIV BIOSCIENCES, LLC
To: ACQUIOM AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 071150/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2022
From: UPADHYAY, ROSHAN GANESHLAL
To: KASHIV BIOSCIENCES, LLC
Reel/Frame 061314/0443 →